Top Health Tech Companies in Denver & Boulder, CO (365)

Investor Backing & Capital Strength: A third funding round reported as a Series C in June 2024, bringing total raised to $200M+, is presented as a scaling‑stage milestone and foundation for continued investment. This capital base aligns with ongoing product rollouts and market expansion efforts.

Strategic Partnerships: Cleveland Clinic expanded its enterprise deployment in 2025, and the Clinic’s own materials later highlighted systemwide use of AKASA’s generative‑AI tools for coding and documentation across U.S. locations. These multi‑site, referenceable wins indicate traction with major health systems.

Product Line Growth: Successive mid‑cycle launches in 2024–2025 (e.g., Authorization Advisor, AKASA Medical Coding, CDI Optimizer) highlight continued R&D and commercialization. This expansion signals a broader roadmap beyond an initial single‑product focus.

Investor Backing & Capital Strength: A $25M Series B on January 23, 2024 led by Viewpoint with participation from American Family Ventures and Primary, alongside a 4x valuation step-up from the 2021 Series A, signals solid capital support. Third-party databases list the same round.

Innovation-Driven Growth: New capabilities and feature releases (e.g., an AI Assistant and ongoing platform enhancements into 2026) are presented alongside sharp year-over-year AEP gains, pointing to product-led expansion. The company also highlights increased agent production and platform-driven efficiency.

Customer Loyalty & Retention: Materials cite +40% average agency enrollment growth after adopting the platform and an 84% average client retention rate. Expanding usage to 10,000+ agents and roughly 250,000 enrollments in 2025 further suggest deepening engagement.

Investor Backing & Capital Strength: In March 2026, TPG’s The Rise Fund invested about $250 million in Findhelp to scale products and go-to-market. This capital is described as fuel to expand the national network and technology.

Market Expansion: State and HIE initiatives are broadening reach, including Tennessee’s Medicaid statewide launch and California’s Manifest MedEx data-sharing integration. These deployments extend coverage to large member populations and embed social–clinical data exchange.

Product Line Growth: The October 2025 acquisition of Uno Health added benefits eligibility and enrollment, positioning the platform as more end‑to‑end. Behavioral-health integrations such as the nationwide SimplePractice connection further widen use cases.

Strong Market Position & Advantage: Industry materials describe Owens & Minor P&HS as a leading national med‑surg distributor with extensive distribution and manufacturing reach, while Accendra’s Apria and Byram operate at national scale in home‑based care. Recognition from major GPOs signals credibility with large health systems.

Strategic Partnerships: National arrangements such as selection for a preferred DME network and supplier performance awards from Vizient indicate strong channel access. These relationships support volume and reinforce account stickiness with large IDN/GPO customers.

Future-Ready Strategy: Management has repositioned the public company as a pure‑play home‑based care platform and initiated a balance‑sheet optimization to support execution. Maintaining 2026 guidance amid the transition suggests planned continuity while the reset proceeds.

Strong Revenue Growth: Operating revenue grew from about $15.9 billion in 2024 to roughly $18 billion in 2025 alongside an operating margin above 4%. Patient encounters also reached a record, rising from about 15.7 million in 2024 to nearly 16 million in 2025.

Market Expansion: The system is adding capacity across geographies, including a $340 million expansion in Avon, a planned private cancer hospital in London by 2027, and continued growth at Cleveland Clinic Abu Dhabi. Scale includes 23 hospitals and 280 outpatient locations as of year‑end 2024, with rising international patient volumes.

Strong Brand Reputation: Global and national rankings place the organization among the top hospitals, including Newsweek’s No. 2 worldwide ranking and continued U.S. News Honor Roll status in 2025–2026. Specialty depth remains broad, with numerous top national placements and No. 1 in Ohio.

Market Expansion: The system is adding regions and facilities, including Overlake joining as a North Sound flagship, Yakima Memorial integration, a new Mary Bridge Children’s campus, and a proposed affiliation with Oregon-based Samaritan. Continued openings across urgent care and outpatient sites further extend access across Washington and into the broader Pacific Northwest.

Strategic Partnerships: Collaborations span a clinically integrated network with UW’s Accountable Care Network, a developing ASC joint venture with Atlas, equity ties with specialty groups, and cross-system projects like the Kootenai Health medical campus. These affiliations provide platforms to scale value-based care and specialty depth while entering adjacent markets.

Strong Market Position & Advantage: Regionally, MultiCare is described as a leading, community-based system in Washington with the state’s largest urgent-care footprint via Indigo and distinctive anchors such as Mary Bridge Children’s trauma designation. Presence across multiple Washington regions and recent recognitions at select hospitals reinforce a durable position in key submarkets like the South Sound and Inland Northwest.

Strong Revenue Growth: Recent reports describe double-digit year-over-year increases in operating revenue, alongside rising net patient service revenue and growing patient volumes.

Market Expansion: Ongoing multiyear capital projects and new facilities in fast-growing Carolinas regions indicate continued geographic and service-line expansion.

Strong Market Position & Advantage: Multiple quality and safety recognitions, along with large integrated scale across hundreds of locations, point to a prominent regional position.